UK markets open in 6 hours 56 minutes
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.29 -0.64 (-0.78%) GOLD FUTURES
2,302.30 -0.60 (-0.03%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
48,541.18 -2,538.88 (-4.97%)
XTL Biopharmaceuticals Ltd. (XTLB)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 12.97M |
| Enterprise value | 10.76M |
| Trailing P/E | 4.84 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 5.27 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -6.28 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.03 |
| 52-week change 3 | 86.15% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 4.9900 |
| 52-week low 3 | 0.7500 |
| 50-day moving average 3 | 1.9258 |
| 200-day moving average 3 | 1.1814 |
Share statistics
| Avg vol (3-month) 3 | 761.28k |
| Avg vol (10-day) 3 | 18.6k |
| Shares outstanding 5 | 5.45M |
| Implied shares outstanding 6 | 5.45M |
| Float 8 | 413.26M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 4.55% |
| Shares short (15 Apr 2024) 4 | 437.16k |
| Short ratio (15 Apr 2024) 4 | 0.03 |
| Short % of float (15 Apr 2024) 4 | N/A |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.11% |
| Shares short (prior month 15 Mar 2024) 4 | 2k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 10 Feb 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5 |
| Last split date 3 | 10 Feb 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -13.06% |
| Return on equity (ttm) | -62.00% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -789k |
| Net income avi to common (ttm) | -2.25M |
| Diluted EPS (ttm) | -0.4000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.21M |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 14.09 |
| Book value per share (mrq) | 0.00 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.